Well, there does seem to be an element of kicking the can down the road. How can one prevent the very well-known side effects of the anti-resorptives (bisphosphonates and Prolia) of odd fractures and osteonecrosis (no matter how 'rare') when taking them after growing bone with other drugs if the anti-resorptives are the only drugs to 'protect' that 'new bone'?

What's needed is an anti-resorptive approach or people can potentially get into a messy cycle as far as I can see. I was looking at a video on sound/vibration being used to kill cancer cells in lab experiments and the professor explaining this mentioned a facility in Toronto having good results with vibratory medicine to increase bone density. That might not pan out or become widely available but something that helps maintain the bone renewal cycle is the solution I'm hoping for.

The good news is that a lot of new developments are possible in 2 years including finding that taking Forteo for a longer period is fine, or for longer on a smaller dose. Or the current emphasis on bone strength will yield a whole new way of ensuring real bone integrity. If one has very little estrogen by that time, then loss of estrogen is no longer a factor to trigger bone renewal falloff so, just maybe, they're find there is less need to 'protect' the new bone anyway. So there are a lot of other possible solutions and two years is a long time in the arena of medical advancements.